S. SÜSGÜN Et Al. , "Assessment of miR-1179 As a Potential Biomarker in Juvenile Myoclonic Epilepsy," EXPERIMED , vol.12, pp.1-4, 2022
SÜSGÜN, S. Et Al. 2022. Assessment of miR-1179 As a Potential Biomarker in Juvenile Myoclonic Epilepsy. EXPERIMED , vol.12 , 1-4.
SÜSGÜN, S., TORUNTAY, C., BAYRAKOĞLU, A., USLU, F. İ., & YÜCESAN, E., (2022). Assessment of miR-1179 As a Potential Biomarker in Juvenile Myoclonic Epilepsy. EXPERIMED , vol.12, 1-4.
SÜSGÜN, Seda Et Al. "Assessment of miR-1179 As a Potential Biomarker in Juvenile Myoclonic Epilepsy," EXPERIMED , vol.12, 1-4, 2022
SÜSGÜN, Seda Et Al. "Assessment of miR-1179 As a Potential Biomarker in Juvenile Myoclonic Epilepsy." EXPERIMED , vol.12, pp.1-4, 2022
SÜSGÜN, S. Et Al. (2022) . "Assessment of miR-1179 As a Potential Biomarker in Juvenile Myoclonic Epilepsy." EXPERIMED , vol.12, pp.1-4.
@article{article, author={Seda SÜSGÜN Et Al. }, title={Assessment of miR-1179 As a Potential Biomarker in Juvenile Myoclonic Epilepsy}, journal={EXPERIMED}, year=2022, pages={1-4} }